[Pulmonary emphysema--the etiology and therapy].
Kawakami
Y
Y
D000280:Administration, Inhalation; D000975:Antioxidants / Q000378:metabolism; D001993:Bronchodilator Agents / Q000008:administration & dosage; D003546:Cysteine Endopeptidases / Q000502:physiology; D010450:Endopeptidases / Q000378:metabolism; D006801:Humans; D016209:Interleukin-8 / Q000502:physiology; D019272:Leukocyte Elastase / Q000502:physiology; D009504:Neutrophils / Q000502:physiology; D016877:Oxidants / Q000378:metabolism; D010102:Oxygen Inhalation Therapy; D011480:Protease Inhibitors / Q000378:metabolism; D011650:Pulmonary Alveoli / Q000378:metabolism / Q000473:pathology; D011656:Pulmonary Emphysema / Q000209:etiology / Q000628:therapy; D012907:Smoking / Q000009:adverse effects
D000975:Antioxidants; D001993:Bronchodilator Agents; D016209:Interleukin-8; D016877:Oxidants; D011480:Protease Inhibitors; D010450:Endopeptidases; D019272:Leukocyte Elastase; D003546:Cysteine Endopeptidases